Pulmonary hypertension and lung diseases: A suggestion for revision of the clinical classification

European Respiratory Journal

Volumn 35, Issue 3, 2010, Pages 700-701

  Tsangaris, I ^a   Orfanos, S ^a   Bouros, D ^b  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE CLASSIFICATION; HISTIOCYTOSIS X; INTERSTITIAL LUNG DISEASE; LETTER; LUNG DISEASE; LYMPHANGIOLEIOMYOMATOSIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SARCOIDOSIS; SMOKING;

HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; HYPERTENSION, PULMONARY; LUNG DISEASES, INTERSTITIAL; LYMPHANGIOLEIOMYOMATOSIS; SARCOIDOSIS, PULMONARY;

EID: 77951186519     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00179709     Document Type: Letter

References (5)

1. Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Respir J 2009; 34: 1219-1263.
2. Travis WD, King TE, Bateman ED, et al. ATS/ERS international multidisciplinary consensus classification of idiopathic interstitial pneumonias. General principles and recommendations. Am J Respir Crit Care Med 2002; 165: 277-304.
3. Baughman RP, Teirstein AS, Judson MA, et al. Case Control Etiologic Study of Sarcoidosis (ACCESS) research group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001; 164: 1885-1889.
4. Nunes H, Humbert M, Capron F, et al. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax 2006; 61: 68-74. (Pubitemid 43106981)
5. Behr J, Ryu JH. Pulmonary hypertension in interstitial lung disease. Eur Respir J 2008; 31: 1357-1367.